These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20880163

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 27. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
    May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM.
    Scand J Urol Nephrol; 2011 Sep; 45(4):251-7. PubMed ID: 21388337
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
    Hugen CM, Polcari AJ, Fitzgerald MP, Dauw C, Flanigan RC, Quek ML.
    J Surg Oncol; 2010 Sep 15; 102(4):334-7. PubMed ID: 20607757
    [Abstract] [Full Text] [Related]

  • 29. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
    Leissner J, Allhoff EP, Hohenfellner R, Wolf HK.
    Zentralbl Chir; 2002 Apr 15; 127(4):315-21. PubMed ID: 12085284
    [Abstract] [Full Text] [Related]

  • 30. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 15; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 31. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, Sakano S, Ohmi C, Gondo T, Naito K.
    BJU Int; 2008 Aug 05; 102(5):572-5. PubMed ID: 18485032
    [Abstract] [Full Text] [Related]

  • 32. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.
    Leissner J, Koeppen C, Wolf HK.
    J Urol; 2003 Mar 05; 169(3):955-60. PubMed ID: 12576821
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE.
    Cancer; 2009 Feb 15; 115(4):770-5. PubMed ID: 19152431
    [Abstract] [Full Text] [Related]

  • 36. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G, Barbareschi M, Brausi M, Gacci M, Luciani LG, Liguori G, Gontero P, Campodonico F, Simonato A, Boddi V, Di Stasi SM, Colombo R, Serretta V, Carmignani G, Malossini G, Altieri V, Carini M, Terrone C, Bassi P, Montorsi F, Ficarra V, Selli C, Mirone V, Bartoletti R.
    Urology; 2014 Nov 15; 84(5):1141-6. PubMed ID: 25239253
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec 15; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 40. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ, Hutterer GC, Shariat SF, Rogers CG, Palapattu GS, Lotan Y, Vazina A, Amiel GE, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Karakiewicz PI, Bladder Cancer Research Consortium.
    BJU Int; 2008 Feb 15; 101(4):450-4. PubMed ID: 17850359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.